In: Targeted Oncology, 2015, vol. 10, no. 2, p. 297-301
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 7, p. 1755-1758
|
In: Langenbeck's Archives of Surgery, 2015, vol. 400, no. 6, p. 675-682
|
In: Gynäkologische Endokrinologie, 2015, vol. 13, no. 2, p. 126-134
|
In: The Journal of Clinical Endocrinology & Metabolism, 2016, vol. 101, no. 9, p. 3409-3418
|
In: Toxicological Sciences, 2017, vol. 160, no. 2, p. 230-243
|
In: Hormone Molecular Biology and Clinical Investigation, 2017, vol. 32, no. 1, p. -
|
In: American Journal of Hypertension, 2016, vol. 29, no. 4, p. 484-493
|
In: The breast, 2020, vol. 52, p. 110-115
Background: Corona Virus Disease 19 (COVID-19) had a worldwide negative impact on healthcare systems, which were not used to coping with such pandemic. Adaptation strategies prioritizing COVID-19 patients included triage of patients and reduction or re-allocation of other services. The aim of our survey was to provide a real time international snapshot of modifications of breast cancer...
|
In: Cancers, 2020, vol. 12, no. 1, p. 223
Membrane-associated guanylate kinase (MAGUK) with inverted domain structure-1 (MAGI1) is an intracellular adaptor protein that stabilizes epithelial junctions consistent with a tumor suppressive function in several cancers of epithelial origin. Here we report, based on experimental results and human breast cancer (BC) patients’ gene expression data, that MAGI1 is highly expressed and acts...
|